OBJECTIVE: The central goal of the study was to analyze the impact of dissociation on the treatment effectiveness in patients with anxiety/neurotic spectrum and depressive disorders with or without comorbid personality disorders. METHODS: The research sample consisted of inpatients who were hospitalized in the psychiatric department and met the ICD-10 criteria for diagnosis of depressive disorder, panic disorder, generalized anxiety disorder, mixed anxiety-depressive disorder, agoraphobia, social phobia, obsessive compulsive disorder, posttraumatic stress disorder, adjustment disorders, dissociative/conversion disorders, somatoform disorder, or other anxiety/neurotic spectrum disorder. The participants completed these measures at the start and end of the therapeutic program - Beck Depression Inventory, Beck Anxiety Inventory, a subjective version of Clinical Global Impression-Severity, Sheehan Patient-Related Anxiety Scale, and Dissociative Experience Scale. RESULTS: A total of 840 patients with anxiety or depressive spectrum disorders, who were resistant to pharmacological treatment on an outpatient basis and were referred for hospitalization for the 6-week complex therapeutic program, were enrolled in this study. Of them, 606 were statistically analyzed. Data from the remaining 234 (27.86%) patients were not used because of various reasons (103 prematurely finished the program, 131 did not fill in most of the questionnaires). The patients' mean ratings on all measurements were significantly reduced during the treatment. Also, 67.5% reached at least minimal improvement (42.4% showed moderate and more improvement, 35.3% of the patients reached remission). The patients without comorbid personality disorder improved more significantly in the reduction of depressive symptoms than those with comorbid personality disorder. However, there were no significant differences in change in anxiety levels and severity of the mental issues between the patients with and without personality disorders. Higher degree of dissociation at the beginning of the treatment predicted minor improvement, and also, higher therapeutic change was connected to greater reduction of the dissociation level. CONCLUSION: Dissociation is an important factor that influences the treatment effectiveness in anxiety/depression patients with or without personality disorders resistant to previous treatment. Targeting dissociation in the treatment of these disorders may be beneficial.

Department of Psychiatry Faculty of Medicine and Dentistry Palacky University in Olomouc University Hospital Olomouc Olomouc

Department of Psychiatry Faculty of Medicine and Dentistry Palacky University in Olomouc University Hospital Olomouc Olomouc; Psychiatric Department Hospital Liberec Liberec Czech Republic

Department of Psychology Sciences Faculty of Social Science and Health Care Constantine the Philosopher University in Nitra Nitra Slovak Republic

See more in PubMed

Cooper J, Carty J, Creamer M. Pharmacotherapy for posttraumatic stress disorder: empirical review and clinical recommendations. Aust N Z J Psychiatry. 2005;39(8):674–682. PubMed

Schmitt R, Gazalle FK, Lima MS, Cunha A, Souza J, Kapczinski F. The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis. Rev Bras Psiquiatr. 2005;27(1):18–24. PubMed

Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med. 2011;155(11):772–785. PubMed

Bandelow B, Reitt M, Röver C, Michaelis S, Görlich Y, Wedekind D. Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol. 2015;30(4):183–192. PubMed

Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(5):403–439. PubMed

Pittenger C, Bloch MH. Pharmacological treatment of obsessive-compulsive disorder. Psychiatr Clin North Am. 2014;37(3):375–391. PubMed PMC

Maneeton N, Maneeton B, Woottiluk P, et al. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2016;10:259–276. PubMed PMC

Cuijpers P, van Straten A, Andersson G, van Oppen P. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol. 2008;76(6):909–922. PubMed

Blais MA, Malone JC, Stein MB, et al. Treatment as usual (TAU) for depression: a comparison of psychotherapy, pharmacotherapy, and combined treatment at a large academic medical center. Psychotherapy (Chic) 2013;50(1):110–118. PubMed

Sadeghi R, Mokhber N, Mahmoudi LZ, Asgharipour N, Seyfi H. A systematic review and meta-analysis of controlled treatment trials of metacognitive therapy for anxiety disorders. J Res Med Sci. 2015;20(9):901–909. PubMed PMC

Barkowski S, Schwartze D, Strauss B, Burlingame GM, Barth J, Rosendahl J. Efficacy of group psychotherapy for social anxiety disorder: A meta-analysis of randomized-controlled trials. J Anxiety Disord. 2016;39:44–64. PubMed

de Vries YA, de Jonge P, van den Heuvel E, Turner EH, Roest AM. Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression. Br J Psychiatry. 2016;208(6):515–521. PubMed

Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. Cochrane Database Syst Rev. 2016;4:CD011004. PubMed PMC

Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety. 2009;26(3):279–288. PubMed

Hetrick SE, Purcell R, Garner B, Parslow R. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD) Cochrane Database Syst Rev. 2010;(7):CD007316. PubMed

Romanelli RJ, Wu FM, Gamba R, Mojtabai R, Segal JB. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Depress Anxiety. 2014;31(8):641–652. PubMed

Huhn M, Tardy M, Spineli LM, et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses. JAMA Psychiatry. 2014;71(6):706–715. PubMed

Stimpson N, Agrawal N, Lewis G. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatry. 2002;181:284–294. PubMed

Thomas L, Kessler D, Campbell J, et al. Prevalence of treatment-resistant depression in primary care: cross-sectional data. Br J Gen Pract. 2013;63(617):e852–e858. PubMed PMC

Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53(8):649–659. PubMed

Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67(Suppl 6):16–22. PubMed

Kubitz N, Mehra M, Potluri RC, Garg N, Cossrow N. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database. PLoS One. 2013;8(10):e76882. PubMed PMC

Spijker J, van Straten A, Bockting CL, Meeuwissen JA, van Balkom AJ. Psychotherapy, antidepressants, and their combination for chronic major depressive disorder: a systematic review. Can J Psychiatry. 2013;58(7):386–392. PubMed

Nil R, Lütolf S, Seifritz E. Residual symptoms and functionality in depressed outpatients: a one-year observational study in Switzerland with escitalopram. J Affect Disord. 2016;197:245–250. PubMed

McIntyre RS, Filteau MJ, Martin L, et al. Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord. 2014;156:1–7. PubMed

Watson S, Chilton R, Fairchild H, Whewell P. Association between childhood trauma and dissociation among patients with borderline personality disorder. Aust N Z J Psychiatry. 2006;40(5):478–481. PubMed

Prasko J, Raszka M, Adamcova K, et al. Predicting the therapeutic response to cognitive behavioral therapy in patients with the pharmacoresistant obsessive-compulsive disorder. Neuroendocrinol Lett. 2009;30(5):615–623. PubMed

Ociskova M, Prasko J, Kamaradova D, Grambal A, Latalova K, Sigmundova Z. Relationship between internalized stigma and treatment efficacy in the mixed neurotic spectrum and depressive disorders. Neuro Endocrinol Lett. 2015;35(8):711–717. PubMed

Zanarini MC, Ruser T, Frankenburg FR, Hennen J. The dissociative experiences of borderline patients. Compr Psychiatry. 2000;41(3):223–227. PubMed

Spiegel D, editor. Dissociation. Washington, DC: American Psychiatric Press; 1994.

Orne MT. The nature of hypnosis: artifact and essence. J Abnorm Psychol. 1959;58(3):277–299. PubMed

Spiegel H, Spiegel D. Trance and Treatment: Clinical Uses of Hypnosis. Washington, DC: American Psychiatric Press; 1987.

Maldonado J, Spiegel D. Trauma, dissociation, and hypnotizability. In: Marmar R, Bremner D, editors. Trauma, Memory, and Dissociation. Washington, DC: American Psychiatric Press; 1998.

Janoff-Bulman R. Shattered Assumptions. New York: The Free Press; 1992.

McCann IL, Pearlman LA. Psychological Trauma and the Adult Survivor. New York: Bruner/Mazel; 1990.

Putnam FW. Traumatic stress and pathological dissociation. Ann N Y Acad Sci. 1995;771:708–715. PubMed

Bremner JD, Brett E. Trauma-related dissociative states and long-term psychopathology in posttraumatic stress disorder. J Trauma Stress. 1997;10(1):37–49. PubMed

Ahrens CE, Aldana E. The ties that bind: understanding the impact of sexual assault disclosure on survivors’ relationships with friends, family, and partners. J Trauma Dissociation. 2012;13(2):226–243. PubMed

Maldonado J, Spiegel D. Treatment of post traumatic stress disorder. In: Lynn S, Rhue J, editors. Dissociation: Clinical, Theoretical, and Research Perspectives. New York, NY: Guilford Press; 1994. pp. 215–241.

Draijer N, Langeland W. Childhood trauma and perceived parental dysfunction in the etiology of dissociative symptoms in psychiatric inpatients. Am J Psychiatry. 1999;156(3):379–385. PubMed

Simeon D, Guralnik O, Schmeidler J, Sirof B, Knutelska M. The role of childhood interpersonal trauma in depersonalization disorder. Am J Psychiatry. 2001;158(7):1027–1033. PubMed

Roy A. Childhood trauma and neuroticism as an adult: possible implication for the development of the common psychiatric disorders and suicidal behavior. Psychol Med. 2002;32:1471–1474. PubMed

McFarlane A, Clark CR, Bryant RA, et al. The impact of early life stress on psychophysiological, personality and behavioral measures in 740 non-clinical subjects. J Integr Neurosci. 2005;4(1):27–40. PubMed

Stein MB, Schork NJ, Gelernter J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology. 2008;33(2):312–319. PubMed

Epstein S. The self-concept, the traumatic neurosis, and the structure of personality. In: Ozer D, Healy JM Jr, Stewart AJ, editors. Perspectives in Personality. 3A. London: Jessica Kingsley; 1991. pp. 63–98.

Tyrer P, Davidson K. Management of personality disorder. In: Gelder MG, Lopez-Ibor JJ, Andreasen A, editors. New Oxford Textbook of Psychiatry. Oxford: Oxford University Press; 2000. pp. 970–978.

Perry JC, Bond M. Empirical studies of psychotherapy for personality disorders. In: Gunderson JG, Gabbard GO, editors. Psychotherapy for Personality Disorders, Review of Psychiatry Series 19/3. Washington DC: American Psychiatric Press; 2000. pp. 1–32.

Prasko J, Houbova P, Novak T, et al. Influence of personality disorder on the treatment of panic disorder – comparison study. Neuro Endocrinol Lett. 2005;26(6):667–674. PubMed

Vyskocilova J, Prasko J, Novak T, Pohlova L. Is there any influence of personality disorder on the short term intensive group cognitive behavioral therapy for social phobia? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(1):85–94. PubMed

Kamaradova D, Prasko J, Sandoval A, Latalova K. Therapeutic response to complex cognitive-behavioral and pharmacological treatment in patients with social phobia. Act Nerv Super Rediviva. 2014;56(3–4):91–99.

Kamarádová D, Praško J, Grambal A, et al. Predictors of therapeutic response in patients with panic disorder identified by demographic and clinical data. [Prediktory terapeutické odpovědi pacientů s panickou poruchou identifikované pomocí demografických a klinických dat] Čes A Slov Psychiat. 2013;109:577–583. Czech.

Sedlackova Z, Prasko J, Latalova K, et al. Psychosocial aspects of resistance in complex treatment of depressive disorder. Neuro Endocrinol Lett. 2015;36(4):354–362. PubMed

Russell JM, Kornstein SG, Shea MT, et al. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. J Clin Psychiatry. 2003;64(5):554–561. PubMed

Kool S, Schoevers R, de Maat S, et al. Efficacy of pharmacotherapy in depressed patients with and without personality disorders: a systematic review and meta-analysis. J Affect Disord. 2005;88(3):269–278. PubMed

Blom MB, Spinhoven P, Hoffman T, et al. Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. J Affect Disord. 2007;104(1–3):119–126. PubMed

Maddux RE, Riso LP, Klein DN, et al. Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination. J Affect Disord. 2009;117(3):174–179. PubMed

Sato T, Sakado K, Sato S, Morikawa T. Cluster a personality disorder: a marker of worse treatment outcome of major depression? Psychiatry Res. 1994;53(2):153–159. PubMed

Bagby RM, Quilty LC, Segal ZV, McBride CC, Kennedy SH, Costa PT. Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy. Can J Psychiatry. 2008;53(6):361–370. PubMed PMC

Levenson JC, Wallace ML, Fournier JC, Rucci P, Frank E. The role of personality pathology in depression treatment outcome with psychotherapy and pharmacotherapy. J Consult Clin Psychol. 2012;80(5):719–729. PubMed PMC

O’Leary D, Costello F. Personality and outcome in depression: an 18-month prospective follow-up study. J Affect Disord. 2001;63(1–3):67–78. PubMed

Galione J, Zimmerman M. A comparison of depressed patients with and without borderline personality disorder: implications for interpreting studies of the validity of the bipolar spectrum. J Pers Disord. 2010;24(6):763–772. PubMed

Prasko J, Latalova K, Diveky T, et al. Panic disorder, autonomic nervous system and dissociation – changes during therapy. Neuro Endocrinol Lett. 2011;32(5):641–651. PubMed

Mezinárodní klasifikace nemocí. 10. revize. [International Classification of the Diseases – 10th edition] Duševní poruchy a poruchy chování: Diagnostická kritéria pro výzkum. Praha: Psychiatrické centrum; 1996. přeloženo z anglického originálu. Czech.

Storch EA, Roberti JW, Roth DA. Factor structure, concurrent validity, and internal consistency of the beck depression inventory – second edition in a sample of college students. Depress Anxiety. 2004;19(3):187–189. PubMed

Preiss M, Vacir K. Beckova sebeposuzovací škála depresivity pro dospělé – BDI-II [Beck Self-Report Depression Scale for Adults – BDI-II] Brno: Psychodiagnostika; 1999.

Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville, US: DHEW; 1976.

Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the Clinical global impression scale among individuals with social anxiety disorder. Psychol Med. 2003;33(4):611–622. PubMed

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897. PubMed

De Ayala RJ, Vonderharr-Carlson DJ, Kim D. Assessing the reliability of the Beck Anxiety Inventory scores. Educ Psychol Meas. 2005;65(5):742–756.

Kamaradova D, Prasko J, Latalova K, et al. Psychometric properties of the Czech version of the Beck Anxiety Inventory – comparison between diagnostic groups. Neuro Endocrinol Lett. 2015;36(7):706–712. PubMed

Sheehan DV, Raj AB, Sheehan KH, Soto S. The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report. Pharmacol Biochem Behav. 1988;29(4):815–817. PubMed

Sheehan DV. Sheehan Patient-Related Anxiety Scale. In: McGlynn TJ, Metcalf HL, editors. Diagnosis and Treatment of Anxiety Disorders: A Physician’s Handbook. Washington, DC: American Psychiatric Press, Inc; 1989. pp. 98–99.

Kick SD, Bell JA, Norris JM, Steiner JF. Validation of two anxiety scales in a university primary care clinic. Psychosom Med. 1994;56(6):570–576. PubMed

Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986;174(12):727–735. PubMed

Spitzer C, Freyberger H, Brähler E, Beutel ME, Stieglitz R. Psychometric evaluation of the Dissociative Experiences Scale-Taxon (DES-T) Psychother Psychosom Med Psychol. 2015;65(3–4):134–139. PubMed

Waller NG, Ross CA. The prevalence and biometric structure of pathological dissociation in the general population: taxometric and behavior genetic findings. J Abnorm Psychol. 1997;106(4):499–510. PubMed

Ptacek R, Bob P, Paclt I. Škála disociativních zkušeností – česká verze [Dissociative Experiences Scale – Czech version] Československa Psychol. 2006;50(3):262–272. Czech.

EMEA 2002. [Accessed August 25, 2016]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003526.pdf.

Prasko J, Kamaradova D, Cakirpaloglu S, et al. Predicting the therapeutic response to intensive psychotherapeutic programs in patients with neurotic spectrum disorders. Act Nerv Super Rediviva. 2015;57(1–2):30–39.

Thomas LJ, Abel A, Ridgway N, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial protocol. Contemp Clin Trials. 2012;33(2):312–319. PubMed

Hollinghurst S, Carroll FE, Abel A, et al. Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: economic evaluation of the CoBalT Trial. Br J Psychiatry. 2014;204(1):69–76. PubMed

Wiles N, Thomas L, Abel A, et al. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment resistant depression in primary care: the CoBalT randomised controlled trial. Health Technol Assess. 2014;18(31):1–167. PubMed PMC

van der Lem R, Stamsnieder PM, van der Wee NJ, van Veen T, Zitman FG. Influence of sociodemographic and socioeconomic features on treatment outcome in RCTs versus daily psychiatric practice. Soc Psychiatry Psychiatr Epidemiol. 2013;48(6):975–984. PubMed

Jakubovski E, Bloch MH. Prognostic subgroups for citalopram response in the STAR*D trial. J Clin Psychiatry. 2014;75(7):738–747. PubMed PMC

Quilty LC, Mainland BJ, McBride C, Bagby RM. Interpersonal problems and impacts: further evidence for the role of interpersonal functioning in treatment outcome in major depressive disorder. J Affect Disord. 2013;150(2):393–400. PubMed

Husain MM, Rush AJ, Wisniewski SR, et al. Family history of depression and therapeutic outcome: findings from STAR*D. J Clin Psychiatry. 2009;70(2):185–195. PubMed

Knorr UB. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder – an experimental medicine blinded controlled trial. Dan Med J. 2012;59(4):B4426. PubMed

De Carlo V, Calati R, Serretti A. Socio-demographic and clinical predictors of non-response. Non-remission in treatment resistant depressed patients: a systematic review. Psychiatry Res. 2016;240:421–430. PubMed

Pitman SR, Hilsenroth MJ. Interpersonal subtypes of anxiety disorder patients: relationship to assessment and treatment variables. J Nerv Ment Dis. 2016;204(7):513–518. PubMed

Gorwood P, Rouillon F, Even C, Falissard B, Corruble E, Moran P. Treatment response in major depression: effects of personality. Br J Psychiatry. 2010;196(2):139–142. PubMed

Cooper AA, Conklin LR. Dropout from individual psychotherapy for major depression: a meta-analysis of randomized clinical trials. Clin Psychol Rev. 2015;40:57–65. PubMed

Pozza A, Andersson G, Dèttore D. What does best evidence tell us about the efficacy of group cognitive-behavioral therapy for obsessive-compulsive disorder? Protocol for a systematic review and meta-analysis. Psychol Res Behav Manag. 2015;8:225–230. PubMed PMC

van Minnen A, Zoellner LA, Harned MS, Mills K. Changes in comorbid conditions after prolonged exposure for PTSD: a literature review. Curr Psychiatry Rep. 2015;17(3):549. PubMed PMC

Lorentzen S, Ruud T, Fjeldstad A, Høglend PA. Personality disorder moderates outcome in short- and long-term group analytic psychotherapy: a randomized clinical trial. Br J Clin Psychol. 2015;54(2):129–146. PubMed

Rufer M, Fricke S, Held D, Cremer J, Hand I. Dissociation and symptom dimensions of obsessive-compulsive disorder: a replication study. Eur Arch Psychiatry Clin Neurosci. 2006;256(3):146–150. PubMed

Gulsun M, Doruk A, Uzun O, Turkbay T, Ozsahin A. Effect of dissociative experiences on drug treatment of panic disorder. Clin Drug Investig. 2007;27(8):583–590. PubMed

Self-Stigma and Treatment Effectiveness in Patients with SSRI Non-Responsive Obsessive-Compulsive Disorder

Self-stigma and treatment effectiveness in patients with anxiety disorders - a mediation analysis